Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema
Public ClinicalTrials.gov record NCT02712008. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Active-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients With Diabetic Macular Edema
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the study was to compare the efficacy of intravitreal (IVT)-administered REGN910-3 compared to intravitreal aflibercept injection (IAI) in improving best corrected visual acuity (BCVA) in participants with diabetic macular edema (DME).
Study identification
- NCT ID
- NCT02712008
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 302 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2, 2016 (Type not available)
- Primary completion
- Jul 10, 2017 (Actual)
- Completion
- Jul 10, 2017 (Actual)
- Last update posted
- Oct 3, 2018
2016 – 2017
United States locations
- U.S. sites
- 51
- U.S. states
- 27
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mesa | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Arcadia | California | — | — |
| Not listed | Beverly Hills | California | — | — |
| Not listed | Mountain View | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | Palm Desert | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | New London | Connecticut | — | — |
| Not listed | Lakeland | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Winter Haven | Florida | — | — |
| Not listed | Augusta | Georgia | — | — |
| Not listed | Decatur | Georgia | — | — |
| Not listed | ‘Aiea | Hawaii | — | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | New Albany | Indiana | — | — |
| Not listed | Shawnee Mission | Kansas | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Portland | Maine | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Rockville | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Grand Rapids | Michigan | — | — |
| Not listed | Jackson | Michigan | — | — |
| Not listed | Minneapolis | Minnesota | — | — |
| Not listed | Florissant | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Bloomfield | New Jersey | — | — |
| Not listed | Edison | New Jersey | — | — |
| Not listed | Teaneck | New Jersey | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | Rochester | New York | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Kingston | Pennsylvania | — | — |
| Not listed | Florence | South Carolina | — | — |
| Not listed | West Columbia | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Germantown | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Abilene | Texas | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Harlingen | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | The Woodlands | Texas | — | — |
| Not listed | Willow Park | Texas | — | — |
| Not listed | Bellevue | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02712008, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2018 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02712008 live on ClinicalTrials.gov.